Oregon Health & Science University Newswire

Oregon Health & Science University Newswire

Comprehensive Real-Time News Feed for Oregon Health & Science University.

Results 1 - 20 of 815 in Oregon Health & Science University

  1. Advanced childhood cancer arrives at OHSURead the original story w/Photo

    Thursday | KOBI NBC5

    Oregon Health and Science University's Doernbecher Children's Hospital is now the first hospital in the Pacific Northwest to offer an advanced cancer treatment for kids. The U.S. Food and Drug has approved CTL109-also known as tisagenlecleucel or "Kymriah"-for one of the most common forms of lethal cancer in children and young adults, acute lymphoblastic leukemia .

    Comment?

  2. Immune markers may predict multiple sclerosis severityRead the original story w/Photo

    Wednesday Sep 20 | Medical News Today

    ... as primary progressive MS. Recently, scientists from Yale University in New Haven, CT, Oregon Health & Science University in Portland, and the University of California set out to understand the molecular mechanisms involved in MS that dictate ...

    Comment?

  3. MyoKardia Presents Additional Positive Data From Phase II Pioneer-HCM ...Read the original story

    Monday Sep 18 | BioSpace

    MyoKardia, Inc. , a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study of mavacamten in symptomatic, obstructive hypertrophic cardiomyopathy patients were presented at the Heart Failure Society of America 's 21st Annual Scientific Meeting in Dallas, TX.

    Comment?

  4. Outcomes of Telemedicine Video-Conferencing Clinic Versus In-Person...Read the original story

    Friday Sep 15 | Circulation

    From the Knight Cardiovascular Institute , Biostatistics and Design Program , Oregon Clinical & Translational Research Institute , Oregon Health and Science University, Portland; and Electrophysiology Department, Portland Veterans Affairs Medical Center, OR . From the Knight Cardiovascular Institute , Biostatistics and Design Program , Oregon Clinical & Translational Research Institute , Oregon Health and Science University, Portland; and Electrophysiology Department, Portland Veterans Affairs Medical Center, OR .

    Comment?

  5. Board member: DermSpectra to revolutionize skin careRead the original story

    Tuesday Sep 19 | UnionLeader.com

    Two months after a newspaper expose about the Manchester VA Medical Center, whistleblower doctors and medical professionals on Monday raised concerns about continued problems at the facility.

    Comment?

  6. Baby trial begins: Developer Jordan Schnitzer fights to remain sole parentRead the original story w/Photo

    Monday Sep 18 | OregonLive.com

    ... the contract because it contained provisions he didn't like. In spring 2017, employees at Oregon Health & Science University, which harvested Sause's eggs, discovered a copy of the contract in their files. It was signed by both Schnitzer and Sause. ...

    Comment?

  7. Scientists discover markers for progressive multiple sclerosisRead the original story w/Photo

    Monday Sep 18 | Medical News

    Scientists have uncovered two closely related cytokines -- molecules involved in cell communication and movement -- that may explain why some people develop progressive multiple sclerosis , the most severe form of the disease. The findings, authored by researchers at Yale University, Oregon Health & Science University, and the University of California point the way toward developing a novel treatment to prevent progressive forms of the disease.

    Comment?

  8. Study uncovers markers for severe form of multiple sclerosisRead the original story w/Photo

    Monday Sep 18 | PhysOrg Weblog

    ... severe form of the disease. The findings, authored by researchers at Yale University, Oregon Health & Science University, and the University of California point the way toward developing a novel treatment to prevent progressive forms of the disease. ...

    Comment?

  9. MyoKardia Presents Additional Positive Data from Phase 2 PIONEER-HCM...Read the original story w/Photo

    Monday Sep 18 | GlobeNewswire

    MyoKardia, Inc. , a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study of mavacamten in symptomatic, obstructive hypertrophic cardiomyopathy patients were presented at the Heart Failure Society of America 's 21st Annual Scientific Meeting in Dallas, TX.

    Comment?

  10. Physicians tweeting about drugs may have conflict of interestRead the original story w/Photo

    Monday Sep 18 | PhysOrg Weblog

    Most physicians on Twitter with a financial conflict of interest and frequent tweets mention specific drugs for which they have a conflict, according to a study published in the September issue of The Lancet Haematology . Victoria Kaestner, from the Oregon Health & Science University in Portland, and colleagues examined whether conflicted physicians tweet about specific products for which they have a FCOI.

    Comment?

  11. Mallinckrodt Is Under Fire Again, This Time From A Reputable, 110...Read the original story w/Photo

    Monday Sep 18 | Seeking Alpha

    They just published a critique of spending on MNK's Acthar, citing that the drug has limited clinical data vs. cheaper options in many indications "I hold physicians to a higher standard," Bourdette said, noting that some alternatives to Acthar cost 1/50th of the drug's price. "It's a mystery to me why someone would be prescribing the drug."

    Comment?

  12. ASTRO Awards Early-Career Research Grants to Physician-ScientistsRead the original story w/Photo

    Monday Sep 18 | Newswise

    ... of immune checkpoint inhibitors when combined with radiation. Shushan Rana, MD, from the Oregon Health & Science University, Portland, Oregon. Dr. Rana will investigate how microRNA, specifically miR-15a, affects endothelial radiosensitivity through ...

    Comment?

  13. AAFP Names Top Physician, Education and Humanitarian AdvocatesRead the original story

    Friday Sep 15 | Digital Video Editing

    ... tinuing education spheres. Saultz served as chair of the Department of Family Medicine at Oregon Health & Science University for 17 years. Last year, he stepped down and now

    Comment?

  14. Studies reveal how shingles vaccine should be used in arthritis patientsRead the original story w/Photo

    Wednesday Aug 30 | Medical News Today

    New research indicates that the live varicella-zoster vaccine - which is given to protect against shingles - elicits robust immune responses in patients when administered several weeks prior to the start of treatment with the arthritis drug tofacitinib. The Arthritis & Rheumatology findings are encouraging because patients with rheumatoid arthritis have a higher risk of developing shingles than other adults, and tofacitinib and certain other disease-modifying antirheumatic drugs are thought to further increase this risk.

    Comment?

  15. Tinnitus could be worsened by antidepressant useRead the original story w/Photo

    Wednesday Aug 23 | Medical News Today

    ... worse. Senior study author Laurence Trussell, Ph.D., of the School of Medicine at Oregon Health & Science University (OHSU) in Portland, and colleagues came to their findings by analyzing the brain tissue of tinnitus mouse models in response to ...

    Comment?

  16. Multiple sclerosis: Antioxidant may slow disease progressionRead the original story w/Photo

    Jul 3, 2017 | Medical News Today

    ... sclerosis (SPMS), compared with a placebo . Lead study author Dr. Rebecca Spain, of the Oregon Health & Science University School of Medicine in Portland, and colleagues recently reported their results in the journal Neuroimmunology & ...

    Comment?

  17. Health insurance expansion via Obamacare linked to fewer cardiac arrestsRead the original story w/Photo

    Jun 29, 2017 | Medical News Today

    ... said study lead author Eric Stecker, M.D., M.P.H., associate professor of cardiology at Oregon Health & Science University's Knight Cardiovascular Institute in Portland, Oregon. "Health insurance allows people to engage in regular medical care, ...

    Comment?

  18. Study: Use of prefabricated blood vessels may revolutionize root canalsRead the original story w/Photo

    Jun 14, 2017 | Medical News Today

    ... Scientific Reports , doi: 10.1038/s41598-017-02532-3, published online 12 June 2017. MLA Oregon Health & Science University. "Study: Use of prefabricated blood vessels may revolutionize root canals." Medical News Today . MediLexicon, Intl., 14 Jun. ...

    Comment?

  19. Novel compound blocks replication of Zika and other viruses by using a cell's innate defense systemRead the original story w/Photo

    May 5, 2017 | Medical News Today

    The cells of vertebrates have evolved pathways that act like an internal defense, inhibiting viral infections by preventing replication of the pathogens. Drugs that activate those existing systems suggest a promising novel approach to treating dangerous infections by Zika and other viruses, say researchers from the Vaccine and Gene Therapy Institute at Oregon Health and Science University , in Portland.

    Comment?

  20. Antibiotics used to treat cystic fibrosis increases risk of permanent hearing lossRead the original story w/Photo

    Feb 27, 2017 | Medical News Today

    ... Cystic Fibrosis , doi: 10.1016/j.jcf.2017.01.006, published online 24 February 2017. MLA Oregon Health & Science University. "Antibiotics used to treat cystic fibrosis increases risk of permanent hearing loss." Medical News Today . MediLexicon, ...

    Comment?